Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

AI predicts on- and off-target activity of RNA-targeting CRISPRs

Artificial intelligence can predict on- and off-target activity of CRISPR tools that target RNA instead of DNA, according to new research published in Nature Biotechnology.

3 Jul 2023

Bluetongue virus carriers active in winter, study finds

Bluetongue virus, an incurable cattle and sheep-killing disease, is spread by tiny flies once thought to disappear in winter. New research demonstrates that though they are harder to find when it's cold, they remain active.

3 Jul 2023

Multiple drug targets for the treatment of influenza identified using AI program

Poolbeg Pharma, a clinical-stage biopharmaceutical company focusing on infectious and other prevalent diseases with a high unmet medical need, announces a significant breakthrough in its world first influenza Artificial Intelligence ('AI') Programme with CytoReason.

1 Jul 2023

Deep learning model could help identify high-risk patients with community-acquired pneumonia

According to an accepted manuscript published in ARRS' own American Journal of Roentgenology (AJR), a deep learning-based model using initial chest radiographs predicted 30-day mortality in patients with community-acquired pneumonia (CAP), improving upon the performance of an established risk prediction tool (i.e., CURB-65 score).

30 Jun 2023

Study identifies the predictors of post-coronavirus disease 2019 (COVID-19) syndrome symptoms

Study identifies the predictors of post-coronavirus disease 2019 (COVID-19) syndrome symptoms.

30 Jun 2023

Advances in influenza research

This interview with Dr. Mohammad S Safiarian, Associate Product Manager at Sino Biological, discusses the advances in influenza research and how effective vaccines are developed.

From Sino Biological Inc. 30 Jun 2023

WHO to declare artificial sweetener aspartame as possible carcinogen

The World Health Organization recently indicated that aspartame will likely be declared a “possible carcinogen to humans.”

29 Jun 2023

Study suggests blood group A may directly influence SARS-CoV-2 infectious risk

Researchers evaluated the association between blood group A and SARS-CoV-2 infections.

29 Jun 2023

Understanding the biological effects of SARS-CoV-2 persistence in children

Researchers analyzed the most recent knowledge about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

29 Jun 2023

Albumedix and Valneva expand collaboration to include newly approved inactivated COVID-19 vaccine

Albumedix Ltd., a recognized global leader in Recombinant Human Albumin (rHA), specializing in the enablement of advanced therapies and biopharmaceuticals, today announces the expansion of its existing collaboration with Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need.

From Albumedix Ltd. 29 Jun 2023

Pyroptosis: A potential therapeutic target for lung cancer

Lung cancer, one of the most aggressive forms of cancer, continues to be a leading cause of death worldwide. Although several new therapies have been developed for this disease, it has a poor prognosis in its advanced stages.

28 Jun 2023

Public health concerns as highly pathogenic avian influenza A(H5N1) virus found in cat in France

Study describes the identification of a highly pathogenic avian influenza A virus in a domestic cat.

28 Jun 2023

Illuminating how children inherit parents’ stressful experiences

Most of us learned in high school that people get half their genes from their father and half from their mother. That's true, but it turns out the way parents contribute to their offspring's genetics is more complicated—and more intriguing.

27 Jun 2023

New Charleston museum nods to historical roots of us health disparities

Maude Callen, a Black nurse-midwife, delivered more than 800 infants across the South Carolina Lowcountry starting in the 1920s, when segregation made it difficult for Black people to get medical care.

27 Jun 2023

Unprecedented outbreak: deadly avian disease sweeps through wild bird species in China

Study reveals the importance of Avibacterium paragallinarum as a potential avian pathogen.

27 Jun 2023

Hospitals urged to adopt new MRSA prevention strategies

A group of five medical organizations have released updated recommendations for the prevention of methicillin-resistant Staphylococcus aureus, known as MRSA, transmission and infection. MRSA causes approximately 10% of hospital-associated infections in the United States and such infections are associated with an increased risk of death. Certain infections caused by MRSA rose by as much as 41% during the pandemic after falling in preceding years.

27 Jun 2023